Skip to main content

Advertisement

Log in

Outcome Following Percutaneous Transhepatic Biliary Drainage (PTBD) in Carcinoma Gallbladder: a Prospective Observational Study

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

Percutaneous biliary drainage (PTBD) is required as palliation and optimization for surgery or chemotherapy in carcinoma gallbladder (GBC) but may be associated with complications. We aimed to study the outcomes, complications, and changes in quality of life in patients with GBC undergoing PTBD.

Methods

A prospective study from July 2018 to December 2019 in patients of GBC presenting with obstructive jaundice was done. Patients planned for PTBD were included in the study. The progression of the disease, complications of PTBD, reinterventions, effects on initiation or completion of chemotherapy, surgical resection or intervention, and overall survival were recorded. Quality of life (QoL) was assessed using the SF-36 questionnaire before and after 4–6 weeks of intervention.

Results

Of 160 patients assessed for inclusion, 60 (mean age 53.7 ± 10.95 years, 27 (45%) males) were eventually included. Eleven patients (18.3%) had metastatic disease at presentation. Of 60 patients undergoing PTBD, none had immediate procedure-related complications, 41 (68%) patients had at least one, and 18 (30%) patients had more than one complication. The most common complication was peri-catheter bile leak (41.6%), followed by catheter dislodgement (30%), blockage (23.3%), and bleeding (10%). Reintervention was required in 32 (53%) patients. There was a significant decrease in QoL after PTBD (P < 0.0001). Median survival after PTBD was 12 weeks.

Conclusion

The high technical success of PTBD does not translate into the improvement of QoL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95:1685–95.

    Article  Google Scholar 

  2. Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K, et al. National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg. 2010;14:1578–91.

    Article  Google Scholar 

  3. D’Angelica M, Dalal KM, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol. 2009;16:806–16.

    Article  Google Scholar 

  4. Grobmyer SR, Lieberman MD, Daly JM. Gallbladder cancer in the twentieth century: single institutions experience. World J Surg. 2004;1(28):47–9.

    Article  Google Scholar 

  5. Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol. 2004;11:310–5.

    Article  Google Scholar 

  6. Redaelli C, Buchler MW, Schiiing MK, Krahenbuhl L, Ruchti C, Blumgart LH, et al. High coincidence of Mirizzi syndrome and gallbladder carcinoma. Surgery. 1997;121:58–63.

    Article  CAS  Google Scholar 

  7. Tran TB, Norton JA, Ethun CG, Pawlik TM, Buettner S, Schmidt C, et al. Gallbladder cancer presenting with jaundice: uniformly fatal or still potentially curable? J Gastrointest Surg. 2017;21:1245–53.

    Article  Google Scholar 

  8. Mishra PK, Saluja SS, Prithiviraj N, Varshney V, Goel N, Patil N. Predictors of curative resection and long term survival of gallbladder cancer – a retrospective analysis. Am J Surg. 2017;214:278–86.

    Article  Google Scholar 

  9. Agarwal AK, Mandal S, Singh S, Bhojwani R, Sakhuja P, Uppal R. Biliary obstruction in gall bladder cancer is not sine qua non of inoperability. Ann Surg Oncol. 2007;14:2831–7.

    Article  Google Scholar 

  10. Saluja S, Gulati M, Garg P, Pal H, Pal S, Sahni P, et al. Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol. 2008;6:944–50.

    Article  Google Scholar 

  11. Nishio H, Ebata T, Yokoyama Y, Igami T, Sugawara G, Nagino M. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection: Ann Surg. 2011;253:953–60.

    PubMed  Google Scholar 

  12. Regimbeau JM, Fuks D, Bachellier P, Le Treut YP, Pruvot FR, Navarro F, et al. Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group. Eur J Surg Oncol EJSO. 2011;37:505–12.

    Article  CAS  Google Scholar 

  13. Moole H, Dharmapuri S, Duvvuri A, Dharmapuri S, Boddireddy R, Moole V, et al. Endoscopic versus percutaneous biliary drainage in palliation of advanced malignant hilar obstruction: a meta-analysis and systematic review. Can J Gastroenterol Hepatol. 2016;2016:1–8.

    Article  Google Scholar 

  14. Sherman S. Endoscopic drainage of malignant hilar obstruction: is one biliary stent enough or should we work to place two? Gastrointest Endosc. 2001;53:681–4.

    Article  CAS  Google Scholar 

  15. Walter T, Ho CS, Horgan AM, Warkentin A, Gallinger S, Greig PD, et al. Endoscopic or percutaneous biliary drainage for Klatskin tumors? J Vasc Interv Radiol. 2013;24:113–21.

    Article  Google Scholar 

  16. Paik WH, Park YS, Hwang J-H, Lee SH, Yoon CJ, Kang S-G, et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc. 2009;69:55–62.

    Article  Google Scholar 

  17. Crosara Teixeira M, Mak MP, Marques DF, Capareli F, Carnevale FC, Moreira AM, et al. Percutaneous transhepatic biliary drainage in patients with advanced solid malignancies: prognostic factors and clinical outcomes. J Gastrointest Cancer. 2013;44:398–403.

    Article  Google Scholar 

  18. Nennstiel S, Weber A, Frick G, Haller B, Meining A, Schmid RM, et al. Drainage-related complications in percutaneous transhepatic biliary drainage: an analysis over 10 years. J Clin Gastroenterol. 2015;49:764–70.

    Article  Google Scholar 

  19. Chu D, Adler DG. Malignant biliary tract obstruction: evaluation and therapy. J Natl Compr Canc Netw. 2010;8:1033–44.

    Article  Google Scholar 

  20. Amin MB, Gress DM, Meyer LR, Edge SB, Greene FL, Byrd DR, et al. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017.

    Book  Google Scholar 

  21. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF- 36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.

    Article  Google Scholar 

  22. Mansfield S. Management of hilar cholangiocarcinoma in the North of England: Pathology, treatment, and outcome. World J Gastroenterol. 2005;11:7625.

    Article  CAS  Google Scholar 

  23. Gupta P, Maralakunte M, Rathee S, Samanta J, Sharma V, Mandavdhare H, et al. Percutaneous transhepatic biliary drainage in patients at higher risk for adverse events: experience from a tertiary care referral center. Abdom Radiol (NY). 2020;45:2547–53.

    Article  Google Scholar 

  24. Knap D, Orlecka N, Judka R, Juza A, Drabek M, Honkowicz M, et al. Biliary duct obstruction treatment with aid of percutaneous transhepatic biliary drainage. Alex J Med. 2016;52:185–91.

    Google Scholar 

  25. Robson PC, Heffernan N, Gonen M, Thornton R, Brody LA, Holmes R, et al. Prospective study of outcomes after percutaneous biliary drainage for malignant biliary obstruction. Ann Surg Oncol. 2010;17:2303–11.

    Article  CAS  Google Scholar 

  26. Dasari BVM, Ionescu MI, Pawlik TM, Hodson J, Sutcliffe RP, Roberts KJ, et al. Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: a systematic review and meta-analysis. J Surg Oncol. 2018;118:477–85.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Study concept and design: HS, VNS. Data acquisition: HS, VNS, TDY, MA, HK, UG. Data analysis: HS, VNS, MA, VS, HM. Drafting the manuscript: HS, VNS, TDY, VS, HM. Supervision: HS, TDY, UG, HK.

Corresponding author

Correspondence to Harjeet Singh.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Subramani, V.N., Avudaiappan, M., Yadav, T.D. et al. Outcome Following Percutaneous Transhepatic Biliary Drainage (PTBD) in Carcinoma Gallbladder: a Prospective Observational Study. J Gastrointest Canc 53, 543–548 (2022). https://doi.org/10.1007/s12029-021-00655-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-021-00655-5

Keywords

Navigation